SYKES 5% DEXTROSE AND 0.9% SODIUM CHLORIDE- dextrose monohydrate and sodium chloride injection solution Marekani - Kiingereza - NLM (National Library of Medicine)

sykes 5% dextrose and 0.9% sodium chloride- dextrose monohydrate and sodium chloride injection solution

sypharma pty ltd - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - sykes 5% dextrose and 0.9% sodium chloride injection is indicated as a source of water and calories for all species.  sykes 5% dextrose and 0.9% sodium chloride injection is contraindicated in patients with a known allergy to corn or corn products.

LACTATED RINGERS- sodium chloride, sodium lactate, potassium chloride, and calcium chloride injection, solution Marekani - Kiingereza - NLM (National Library of Medicine)

lactated ringers- sodium chloride, sodium lactate, potassium chloride, and calcium chloride injection, solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - sodium chloride 0.6 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. the use of lactated ringer’s injection usp is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, lactate, or chloride could be clinically detrimental. lactate administration is contraindicated in severe metabolic acidosis or alkalosis, and in severe liver disease or anoxic states which affect lactate metabolism.

NORMOSOL-M AND DEXTROSE- dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate injection, solution Marekani - Kiingereza - NLM (National Library of Medicine)

normosol-m and dextrose- dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate injection, solution

hospira, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152), magnesium acetate (unii: 0e95jzy48k) (magnesium cation - unii:t6v3lhy838) - dextrose monohydrate 5 g in 100 ml - normosol-m and 5% dextrose injection (multiple electrolytes and 5% dextrose injection type 1, usp) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose. magnesium in the formula may help to prevent iatrogenic magnesium deficiency in patients receiving prolonged parenteral therapy. none known.

VETERINARY LACTATED AND 5% DEXTROSE- dextrose hydrous, sodium chloride, sodium lactate, potassium chloride, calcium chloride inj Marekani - Kiingereza - NLM (National Library of Medicine)

veterinary lactated and 5% dextrose- dextrose hydrous, sodium chloride, sodium lactate, potassium chloride, calcium chloride inj

ivali llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - lactated ringer's and 5% dextrose injection, usp is indicated as a source of water and electrolytes and calories or as an alkalinizing agent. solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products 

DELFLEX- dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride solution Marekani - Kiingereza - NLM (National Library of Medicine)

delflex- dextrose monohydrate, sodium chloride, sodium lactate, calcium chloride, magnesium chloride solution

fresenius medical care north america - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - dextrose monohydrate 1.5 g in 100 ml - delflex® is indicated in the treatment of chronic kidney failure in patients being maintained on peritoneal dialysis. none. risk summary delflex solutions consist of electrolytes, lactate, and bicarbonate at physiological levels, and glucose to facilitate ultrafiltration. while there are no adequate and well controlled studies in pregnant women, appropriate administration of delflex with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm. animal reproduction studies have not been conducted with delflex. the estimated background risk of major birth defects and miscarriage for the indicated population are unknown. all pregnancies have a background risk of birth defect, loss or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary the components of delflex solutions are excreted in human milk. appropriat

DELFLEX  NEUTRAL PH- dextrose monohydrate, sodium chloride, calcium chloride, magnesium chloride, sodium lactate solution Marekani - Kiingereza - NLM (National Library of Medicine)

delflex neutral ph- dextrose monohydrate, sodium chloride, calcium chloride, magnesium chloride, sodium lactate solution

fresenius medical care north america - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - dextrose monohydrate 1.5 g in 100 ml - delflex® peritoneal dialysis solutions are indicated in the treatment of chronic renal failure patients being maintained on peritoneal dialysis when nondialytic medical therapy is judged to be inadequate. none known.

SODIUM CHLORIDE 0.45 % INJECTION Israeli - Kiingereza - Ministry of Health

sodium chloride 0.45 % injection

neopharm (israel) 1996 ltd - sodium chloride - solution for injection - sodium chloride 0.45 g / 100 ml - sodium chloride - sodium chloride - supply of water for administration of electrolytes. vehicle for therapeutic regimen.

Sodium Chloride 0.9% Malta - Kiingereza - Medicines Authority

sodium chloride 0.9%

demo s.a. pharmaceutical industry 21st km national road athens - lamia 14568 krioneri, greece - sodium chloride - solution for injection - sodium chloride 9 mg/ml - blood substitutes and perfusion solutions

ISOLYTE S- sodium chloride, sodium gluconate, sodium acetate, potassium chloride, and magnesium chloride injection, solution Marekani - Kiingereza - NLM (National Library of Medicine)

isolyte s- sodium chloride, sodium gluconate, sodium acetate, potassium chloride, and magnesium chloride injection, solution

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37, gluconic acid - unii:r4r8j0q44b), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - sodium chloride 0.53 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration, and as an alkalinizing agent. this solution is contraindicated where the administration of sodium, potassium, magnesium, chloride, acetate or gluconate could be clinically detrimental.

TPN ELECTROLYTES- sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous injection, solution, concentrate Marekani - Kiingereza - NLM (National Library of Medicine)

tpn electrolytes- sodium chloride, calcium chloride, potassium chloride, magnesium chloride, and sodium acetate anhydrous injection, solution, concentrate

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc) - sodium chloride 321 mg in 20 ml - tpn electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients. tpn electrolytes (multiple electrolyte additive) is contraindicated in pathological conditions where additives of potassium, sodium, calcium, magnesium or chloride could be clinically deleterious, e.g., anuria, hyperkalemia, heart block or myocardial damage and severe edema due to cardiovascular, renal or hepatic failure. none known.